跳至主要内容
临床试验/NCT00001127
NCT00001127已完成3 期

Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza

National Institute of Allergy and Infectious Diseases (NIAID)1 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2001年8月31日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
15,000
试验地点
1

研究概览

简要总结

This study tests the safety and effectiveness of a flu vaccine in school children.

School children are usually the first members of a community to come down with the flu, and they often give the flu to their younger siblings, parents, and grandparents. It is hoped that giving school children a flu vaccine can help prevent the spread of the flu to other members of the community.

详细描述

This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.

研究设计

研究类型
Interventional
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Months 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Your child may be eligible for this study if he/she:
  • •Is between the ages of 18 months and 18 years, with consent of parent or guardian.
  • •Is a resident of the Temple-Belton, Texas area.

排除标准

  • •Your child will not be eligible for this study if he/she:
  • •Has had a fever within 3 days before vaccination.
  • •Has symptoms of a weakened immune system.
  • •Has had a wheezing episode within the past 2 weeks.
  • •Has moderate to severe asthma.
  • •Is allergic to eggs.
  • •Needs to take aspirin on a regular basis.
  • •Has received another vaccine or study drug in the past month.

研究者

研究点 (1)

Loading locations...

相似试验